180 Life Sciences Corp. (NASDAQ: ATNF) in Hot Pursuit of New Anti-Inflammatory Blockbusters
25 mars 2021 08h30 HE
|
180 Life Sciences Corp.
NEW YORK, March 25, 2021 (GLOBE NEWSWIRE) -- via InvestorWire — 180 Life Sciences Corp. (NASDAQ: ATNF) today announces its placement in an editorial published by NetworkNewsWire ("NNW"), one of 50+...
180 Life Sciences Corp. CEO James Woody, MD, PhD Issues Letter to Stockholders
24 mars 2021 08h30 HE
|
180 Life Sciences Corp.
MENLO PARK, Calif., March 24, 2021 (GLOBE NEWSWIRE) -- 180 Life Sciences Corp. (NASDAQ: ATNF, the "Company"), a clinical-stage biotechnology company with its lead indication in Phase 2b/3 clinical...
180 Life Sciences Corp. to Present at Inaugural Emerging Growth Virtual Conference, presented by M Vest LLC and Maxim Group LLC
08 mars 2021 13h30 HE
|
180 Life Sciences Corp.
MENLO PARK, Calif., March 08, 2021 (GLOBE NEWSWIRE) -- 180 Life Sciences Corp. (NASDAQ: ATNF) (180 Life Sciences or the "Company"), a clinical-stage biotechnology company with its lead indication in...
180 Life Sciences Corp. Announces Closing of $11.7 Million Private Placement
24 févr. 2021 16h00 HE
|
180 Life Sciences Corp.
MENLO PARK, Calif., Feb. 24, 2021 (GLOBE NEWSWIRE) -- 180 Life Sciences Corp. (NASDAQ: ATNF) (180 Life Sciences or the "Company"), a clinical-stage biotechnology company with its lead indication in...
180 Life Sciences Corp. Announces $11.7 Million Private Placement
19 févr. 2021 09h00 HE
|
180 Life Sciences Corp.
MENLO PARK, Calif., Feb. 19, 2021 (GLOBE NEWSWIRE) -- 180 Life Sciences Corp. (NASDAQ: ATNF) (180 Life Sciences or the "Company"), a clinical-stage biotechnology company with its lead indication in...
180 Life Sciences Corp. to Present at the H.C. Wainwright Bioconnect 2021 Conference
05 janv. 2021 14h50 HE
|
180 Life Sciences Corp.
MENLO PARK, Calif., Jan. 05, 2021 (GLOBE NEWSWIRE) -- 180 Life Sciences Corp. (NASDAQ: ATNF) (180 Life Sciences or the "Company"), a clinical-stage biotechnology company with its lead indication in...
180 Life Sciences Corp. to Present at the 13th Annual LD Micro Main Event Conference on Tuesday, December 15th at 1:40 PM EST
03 déc. 2020 11h08 HE
|
180 Life Sciences Corp.
MENLO PARK, Calif., Dec. 03, 2020 (GLOBE NEWSWIRE) -- 180 Life Sciences Corp. (NASDAQ: ATNF) ("180 Life Sciences" or "the Company"), a clinical-stage biotechnology company with its lead indication...
180 Life Sciences Corp. to Ring Nasdaq Opening Bell on November 27, 2020
24 nov. 2020 10h00 HE
|
180 Life Sciences Corp.
MENLO PARK, Calif., Nov. 24, 2020 (GLOBE NEWSWIRE) -- 180 Life Sciences Corp. (NASDAQ: ATNF) (180 Life Sciences or the "Company"), a clinical-stage biotechnology company with its lead indication in...
180 Life Sciences Corp. Continues to Expand Intellectual Property Portfolio With Additional Patent Grants
23 nov. 2020 08h30 HE
|
180 Life Sciences Corp.
MENLO PARK, Calif., Nov. 23, 2020 (GLOBE NEWSWIRE) -- 180 Life Sciences Corp. (NASDAQ: ATNF or the "Company"), a clinical-stage biotechnology company with its lead indication in Phase 2b/3, focused...
180 Life Sciences Corp. CEO James Woody, MD, PhD Issues Letter to Stockholders
17 nov. 2020 08h00 HE
|
180 Life Sciences Corp.
MENLO PARK, Calif., Nov. 17, 2020 (GLOBE NEWSWIRE) -- 180 Life Sciences Corp. (NASDAQ: ATNF or the "Company"), a clinical-stage biotechnology company with its lead indication in Phase 2b/3, focused...